HSBC Holdings’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $84.6M | Sell |
463,652
-40,180
| -8% | -$7.4M | 0.04% | 378 |
|
|
2025
Q4 | $88.8M | Buy |
503,832
+56,314
| +13% | +$9.2M | 0.05% | 349 |
|
|
2025
Q3 | $62.6M | Buy |
447,518
+4,249
| +1% | +$574K | 0.03% | 434 |
|
|
2025
Q2 | $55.6M | Sell |
443,269
-40,760
| -8% | -$5.08M | 0.03% | 459 |
|
|
2025
Q1 | $66M | Buy |
484,029
+43,028
| +10% | +$6.15M | 0.04% | 404 |
|
|
2024
Q4 | $67.2M | Buy |
441,001
+26,605
| +6% | +$4.49M | 0.04% | 413 |
|
|
2024
Q3 | $80.3M | Buy |
414,396
+35,959
| +10% | +$7.52M | 0.05% | 371 |
|
|
2024
Q2 | $87.7M | Sell |
378,437
-20,405
| -5% | -$4.43M | 0.05% | 313 |
|
|
2024
Q1 | $86M | Buy |
398,842
+73,234
| +22% | +$17.2M | 0.06% | 316 |
|
|
2023
Q4 | $84.2M | Buy |
325,608
+52,974
| +19% | +$13M | 0.07% | 279 |
|
|
2023
Q3 | $70.1M | Sell |
272,634
-10,875
| -4% | -$2.91M | 0.07% | 286 |
|
|
2023
Q2 | $80.7M | Buy |
283,509
+33,429
| +13% | +$9.95M | 0.08% | 239 |
|
|
2023
Q1 | $69.5M | Sell |
250,080
-31,858
| -11% | -$8.82M | 0.08% | 244 |
|
|
2022
Q4 | $77.6M | Buy |
281,938
+111,755
| +66% | +$31.6M | 0.09% | 232 |
|
|
2022
Q3 | $45.4M | Sell |
170,183
-36,149
| -18% | -$7.68M | 0.07% | 267 |
|
|
2022
Q2 | $42.4M | Buy |
206,332
+40,071
| +24% | +$8.19M | 0.06% | 331 |
|
|
2022
Q1 | $35.1M | Buy |
166,261
+10,034
| +6% | +$2.18M | 0.04% | 420 |
|
|
2021
Q4 | $37.6M | Buy |
156,227
+400
| +0.3% | +$103K | 0.03% | 477 |
|
|
2021
Q3 | $44.3M | Sell |
155,827
-18,240
| -10% | -$5.98M | 0.04% | 368 |
|
|
2021
Q2 | $60.2M | Sell |
174,067
-88,967
| -34% | -$27M | 0.06% | 286 |
|
|
2021
Q1 | $73.2M | Sell |
263,034
-6,908
| -3% | -$1.86M | 0.09% | 225 |
|
|
2020
Q4 | $65.8M | Buy |
269,942
+38,382
| +17% | +$9.9M | 0.09% | 211 |
|
|
2020
Q3 | $65.7M | Sell |
231,560
-39,559
| -15% | -$11M | 0.1% | 167 |
|
|
2020
Q2 | $72.5M | Buy |
271,119
+77,992
| +40% | +$23.4M | 0.14% | 129 |
|
|
2020
Q1 | $61M | Sell |
193,127
-150,229
| -44% | -$45.6M | 0.14% | 136 |
|
|
2019
Q4 | $101M | Buy |
343,356
+78,036
| +29% | +$21.7M | 0.18% | 107 |
|
|
2019
Q3 | $61.8M | Sell |
265,320
-2,044
| -0.8% | -$476K | 0.12% | 175 |
|
|
2019
Q2 | $62.5M | Sell |
267,364
-44,384
| -14% | -$10.2M | 0.12% | 159 |
|
|
2019
Q1 | $73.7M | Buy |
311,748
+91,994
| +42% | +$29M | 0.13% | 152 |
|
|
2018
Q4 | $66.1M | Sell |
219,754
-3,856
| -2% | -$1.23M | 0.12% | 165 |
|
|
2018
Q3 | $79M | Buy |
223,610
+26,419
| +13% | +$9.1M | 0.13% | 155 |
|
|
2018
Q2 | $57.2M | Sell |
197,191
-166,909
| -46% | -$46.9M | 0.1% | 165 |
|
|
2018
Q1 | $99.7M | Buy |
364,100
+35,143
| +11% | +$10.9M | 0.15% | 120 |
|
|
2017
Q4 | $105M | Sell |
328,957
-16,783
| -5% | -$5.38M | 0.15% | 128 |
|
|
2017
Q3 | $108M | Buy |
345,740
+42,816
| +14% | +$12.7M | 0.17% | 107 |
|
|
2017
Q2 | $82.2M | Buy |
302,924
+20,912
| +7% | +$5.53M | 0.15% | 122 |
|
|
2017
Q1 | $77M | Buy |
282,012
+92,123
| +49% | +$26M | 0.16% | 112 |
|
|
2016
Q4 | $53.8M | Buy |
189,889
+14,462
| +8% | +$4.29M | 0.13% | 173 |
|
|
2016
Q3 | $54.7M | Buy |
175,427
+3,668
| +2% | +$1.09M | 0.14% | 148 |
|
|
2016
Q2 | $41.5M | Sell |
171,759
-49
| -0% | -$12.9K | 0.11% | 200 |
|
|
2016
Q1 | $44.5M | Sell |
171,808
-64,169
| -27% | -$17M | 0.13% | 188 |
|
|
2015
Q4 | $72.4M | Sell |
235,977
-127,376
| -35% | -$36.6M | 0.17% | 117 |
|
|
2015
Q3 | $106M | Sell |
363,353
-6,606
| -2% | -$2.18M | 0.27% | 81 |
|
|
2015
Q2 | $149M | Sell |
369,959
-23,695
| -6% | -$9.51M | 0.3% | 69 |
|
|
2015
Q1 | $166M | Buy |
393,654
+26,769
| +7% | +$10.6M | 0.32% | 63 |
|
|
2014
Q4 | $125M | Buy |
366,885
+49,843
| +16% | +$16.1M | 0.26% | 79 |
|
|
2014
Q3 | $105M | Sell |
317,042
-33,404
| -10% | -$11M | 0.22% | 95 |
|
|
2014
Q2 | $111M | Buy |
350,446
+17,700
| +5% | +$5.33M | 0.24% | 94 |
|
|
2014
Q1 | $101M | Buy |
332,746
+31,897
| +11% | +$10.1M | 0.24% | 90 |
|
|
2013
Q4 | $84.1M | Buy |
300,849
+22,756
| +8% | +$5.89M | 0.22% | 93 |
|
|
2013
Q3 | $67.1M | Buy |
278,093
+7,623
| +3% | +$1.71M | 0.18% | 121 |
|
|
2013
Q2 | $58M | Buy |
+270,470
| New | +$57.8M | 0.17% | 118 |
|
Other funds holding BIIB
VCM
VPM
HSBC Holdings's BIIB Position: Q1 2026 in Review
HSBC Holdings reduced its Biogen (BIIB) stake by 8% in Q1 2026, selling an estimated $7.4M and leaving 463,652 shares worth $84.6M. The position accounts for 0.04% of the portfolio, ranked #378.
HSBC Holdings first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $166M in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- HSBC Holdings held 463,652 shares of Biogen worth $84.6M as of Q1 2026.
- HSBC Holdings sold 40,180 Biogen shares in Q1 2026, an estimated $7.4M.
- Biogen made up 0.04% of HSBC Holdings's portfolio in Q1 2026, its #378 holding.
- HSBC Holdings first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Biogen position peaked at $166M in Q1 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.